- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05190367
Influence of Trauma on Pain Area and Widespreadness in Chronic Pain Patients
It is well known that patients suffering from chronic pain report higher levels of pain, anxiety, and depression if they have experienced a traumatic event. However, little is know about pain area and widespreadness.
In this retrospective study, we want to investigate whether pain area and widespreadness differs in chronic pain patients with and without traumatic events. To test this hypothesis we will retrospectively analyse pain drawings collected at the pain outpatient department from Hannover Medical School. Participants will be divided into four groups depending on the severity of their traumatic events: no trauma; accidental trauma; interpersonal trauma; post-traumatic stress disorder (PTSD).
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Hannover, Germania, 30625
- Hannover Medical School
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Chronic pain
Exclusion Criteria:
- None
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
---|
No trauma
Patients suffering from chronic pain without traumatic life events
|
Accidental trauma
Patients suffering from chronic pain who have experienced at least one accidental trauma
|
Interpersonal trauma
Patients suffering from chronic pain who have experienced at least one interpersonal trauma
|
PTSD
Patients suffering from chronic pain and diagnosed with PTSD
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Difference in pain area
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Pain area derived from electronic pain drawings (SymptomMapper).
The score ranges from 0 to 100% body area.
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in pain widespreadness
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Widespread pain index (WPI) derived from electronic pain drawings (SymptomMapper).
The score ranges from 0 (no pain) to 19 (pain affects all possible regions).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Difference in current pain
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Visual analogue scale from 0 ("no pain") to 100 ("maximal imaginable pain").
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in mean pain in the last four weeks
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Visual analogue scale from 0 ("no pain") to 100 ("maximal imaginable pain").
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in maximal pain in the last four weeks
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Visual analogue scale from 0 ("no pain") to 100 ("maximal imaginable pain").
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in acceptable pain
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Visual analogue scale from 0 ("no pain") to 100 ("maximal imaginable pain").
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in sleep impairment
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Visual analogue scale from 0 ("no impairment") to 100 ("maximal imaginable impairment").
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in pain-related disability
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Pain-related disability assessed via the Pain Disability Index (PDI).
The score ranges from 0 (no pain-related disability) to 70 (maximal disability).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in depression
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Depression assessed via the 9-item depression scale (PHQ-9) from the German version of the Patient Health Questionnaire (PHQ-D).
The score ranges from 0 (no depression) to 27 (maximal depression).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in somatic symptoms
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Somatic symptoms assessed via the 15-item somatic scale (PHQ-15) from the German version of the Patient Health Questionnaire (PHQ-D).
The score ranges from 0 (no somatic symptom burden) to 30 (maximal somatic symptom burden).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in anxiety
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Anxiety assessed via the 7-item anxiety scale (GAD-7) from the German version of the Patient Health Questionnaire (PHQ-D).
The score ranges from 0 (no anxiety) to 21 (maximal anxiety).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Difference in stress
Lasso di tempo: First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Stress assessed via the 10-item stress scale (PHQ-Stress) from the German version of the Patient Health Questionnaire (PHQ-D).
The score ranges from 0 (no stress) to 20 (maximal stress).
|
First visit of each patient at the Pain outpatient department of Hannover Medical School between 2019-02-28 and 2020-07-07
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Jorge Manuel Sánchez, Hannover Medical School
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 9681 (Altro identificatore: CTEP)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Dolore cronico
-
University of OklahomaThe Children's Hospital at OU Medical CenterCompletatoDolore addominale funzionale | Crisi falciforme | Pazienti seguiti dal Pain Team